{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:33:52Z","timestamp":1775666032489,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korea Epilepsy Society","award":["2019001"],"award-info":[{"award-number":["2019001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.yebeh.2020.106942","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T13:59:51Z","timestamp":1583762391000},"page":"106942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Treatment of epilepsy in adults: Expert opinion in South Korea"],"prefix":"10.1016","volume":"105","author":[{"given":"Jung-Ick","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Ik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Geun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joo","family":"No","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daeyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Moon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2020.106942_bb0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2020.106942_bb0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3988\/jcn.2016.12.4.434","article-title":"Estimating the prevalence of treated epilepsy using administrative health data and its validity: ESSENCE study","volume":"12","author":"Lee","year":"2016","journal-title":"J Clin Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.106942_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3346\/jkms.2012.27.3.285","article-title":"Prevalence of treated epilepsy in Korea based on national health insurance data","volume":"27","author":"Lee","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"9566","key":"10.1016\/j.yebeh.2020.106942_bb0020","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"Suppl Suppl 2","key":"10.1016\/j.yebeh.2020.106942_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/epi4.12239","article-title":"From clinical trials of antiepileptic drugs to treatment","volume":"3","author":"Perucca","year":"2018","journal-title":"Epilepsia Open"},{"issue":"4","key":"10.1016\/j.yebeh.2020.106942_bb0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1684\/j.1950-6945.2004.tb00074.x","article-title":"The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey","volume":"6","author":"Semah","year":"2004","journal-title":"Epileptic Disord"},{"issue":"6","key":"10.1016\/j.yebeh.2020.106942_bb0035","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1006\/ebeh.2001.0283","article-title":"The expert consensus guideline series: treatment of epilepsy","volume":"2","author":"Karceski","year":"2001","journal-title":"Epilepsy Behav"},{"issue":"7 Suppl 1","key":"10.1016\/j.yebeh.2020.106942_bb0040","article-title":"Treatment of epilepsy in adults: expert opinion","volume":"2005","author":"Karceski","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.106942_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yebeh.2016.11.018","article-title":"Epilepsy treatment in adults and adolescents: expert opinion, 2016","volume":"69","author":"Shih","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"60 Suppl 1","key":"10.1016\/j.yebeh.2020.106942_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/epi.14458","article-title":"Epilepsy in Asia: disease burden, management barriers, and challenges","author":"Trinka","year":"2019","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106942_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yebeh.2011.10.018","article-title":"Treatment of epilepsy in adults: expert opinion in China","volume":"23","author":"Yu","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2020.106942_bb0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.yebeh.2013.05.038","article-title":"Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: an Italian multicenter prospective observational study","volume":"28","author":"Millul","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2020.106942_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2009.02238.x","article-title":"Rational polytherapy","volume":"50","author":"French","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106942_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14581\/jer.19002","article-title":"Antiepileptic drug therapy in patients with drug-resistant epilepsy","volume":"9","author":"Park","year":"2019","journal-title":"Epilepsy Res"},{"issue":"14","key":"10.1016\/j.yebeh.2020.106942_bb0075","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.yebeh.2020.106942_bb0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1684\/epd.2012.0511","article-title":"What clinical trial designs have been used to test antiepileptic drugs and do we need to change them?","volume":"14","author":"Perucca","year":"2012","journal-title":"Epileptic Disord"},{"issue":"9566","key":"10.1016\/j.yebeh.2020.106942_bb0085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106942_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2020.106942_bb0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/epi.12926","article-title":"A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy","volume":"56","author":"Werhahn","year":"2015","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2020.106942_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"issue":"7","key":"10.1016\/j.yebeh.2020.106942_bb0105","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/epi.16068","article-title":"The medical treatment of epilepsy in the elderly: a systematic review and meta-analysis","volume":"60","author":"Lezaic","year":"2019","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2020.106942_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2020.106942_bb0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11940-012-0180-y","article-title":"Seizure treatment in transplant patients","volume":"14","author":"Shepard","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.yebeh.2020.106942_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.seizure.2019.06.019","article-title":"An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy","volume":"70","author":"Julie","year":"2019","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106942_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14581\/jer.11001","article-title":"Consensus guideline for the assessment of fitness for private driving of persons with epilepsy in Korea","volume":"1","author":"Lee","year":"2011","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019313939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019313939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:31:18Z","timestamp":1761503478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019313939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"alternative-id":["S1525505019313939"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.106942","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of epilepsy in adults: Expert opinion in South Korea","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.106942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106942"}}